PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia

Neuroscience Letters

Volumn 420, Issue 3, 2007, Pages 235-239

  Hou, Xiao Yu ^a   Liu, Yong ^a   Zhang, Guang Yi ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Brain ischemia; N Methyl d aspartate receptor; Neuroprotection; Postsynaptic density protein 95; Src; Tyrosine phosphorylation

Indexed keywords

4 AMINO 7 PHENYLPYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG TARGETING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HISTOLOGY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; ENZYME INHIBITORS; HIPPOCAMPUS; IMMUNOPRECIPITATION; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PYRAMIDAL CELLS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION INJURY; SRC-FAMILY KINASES; TYROSINE;

EID: 34249774266     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.03.048     Document Type: Article

References (18)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., and Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298 (2002) 846-850
2. Davis M.J., Wu X., Nurkiewicz T.R., Kawasaki J., Gui P., Hill M.A., and Wilson E. Regulation of ion channels by protein tyrosine phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1835-H1862
3. Fisher M., and Schaebitz M. An overview of acute stroke therapy: past, present, and future. Arch. Intern. Med. 160 (2000) 3196-3206
4. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
5. Hedrick T.M., Wei L., Francis K., and Ping Y.S. Critical roles of Src family tyrosine kinases in excitatory neuronal differentiation of cultured embryonic stem cells. Exp. Cell Res. 312 (2006) 3096-3107
6. Hou X.Y., Zhang G.Y., Wang D.G., Guan Q.H., and Yan J.Z. Suppression of postsynaptic density protein 95 by antisense oligonucleotides diminishes postischemic pyramidal cell death in a in rat hippocampal CA1 subfield. Neurosci. Lett. 385 (2005) 230-233
7. Hou X.Y., Zhang G.Y., Yan J.Z., Chen M., and Liu Y. Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia. Brain Res. 955 (2002) 123-132
8. Hou X.Y., Zhang G.Y., and Zong Y.Y. Suppression of postsynaptic density protein 95 expression attenuates increased tyrosine phosphorylation of NR2A subunits of N-methyl-d-aspartate-aspartate receptors and interactions of Src and Fyn with NR2A after transient brain ischemia in rat hippocampus. Neurosci. Lett. 343 (2003) 125-128
9. Kemp J.A., and McKernan R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. 5 Suppl. (2002) 1039-1042
10. Kohr G., and Seeburg P.H. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. 492 (1996) 445-452
11. Lennmyr F., Ericsson A., Gerwins P., Akterin S., Ahlstrom H., and Terent A. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol. Scand. 110 (2004) 175-179
12. Liu Y., Hou X.Y., Zhang G.Y., and Xu T.L. L-type voltage-gated calcium channel attends regulation of tyrosine phosphorylation of NMDA receptor subunit 2A induced by transient brain ischemia. Brain Res. 972 (2003) 142-148
13. Liu Y., Zhang G.Y., Gao C., and Hou X.Y. NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A (NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion. Brain Res. 909 (2001) 51-58
14. Pei L., Li Y., Zhang G.Y., Cui Z.C., and Zhu Z.M. Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion. Acta Pharmacol. Sin. 21 (2000) 695-700
15. Pei D.S., Wang X.T., Liu Y., Sun Y.F., Guan Q.H., Wang W., Yan J.Z., Zong Y.Y., Xu T.L., and Zhang G.Y. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. Brain 129 (2006) 465-479
16. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., and Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284 (1999) 1845-1848
17. Tang X., Feng Y., and Ye K. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ. 14 (2007) 368-377
18. Tezuka T., Umemori H., Akiyama T., Nakanishi S., and Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-d-aspartate-aspartate receptor subunit NR2A. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 435-440